Two-Pill combo aims to shield fragile vessels from heart attacks

NCT ID NCT06887062

Summary

This study is testing if two existing blood pressure medications can improve blood vessel health and reduce the risk of heart disease in people with large vessel vasculitis (LVV). Sixty participants, including people with LVV in remission and healthy volunteers, will take the drugs for 10 weeks. Researchers will measure how well the blood vessels relax and how stiff they are to see if the treatment helps.

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for GIANT CELL ARTERITIS (GCA) are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • University of Edinburgh

    RECRUITING

    Edinburgh, EH16 4TJ, United Kingdom

    Contact Phone: •••-•••-•••• Email: •••••@•••••

Conditions

Explore the condition pages connected to this study.